Akira Ohneda

2.4k total citations
112 papers, 1.9k citations indexed

About

Akira Ohneda is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Akira Ohneda has authored 112 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Endocrinology, Diabetes and Metabolism, 52 papers in Surgery and 23 papers in Molecular Biology. Recurrent topics in Akira Ohneda's work include Diabetes Treatment and Management (51 papers), Pancreatic function and diabetes (45 papers) and Diabetes Management and Research (19 papers). Akira Ohneda is often cited by papers focused on Diabetes Treatment and Management (51 papers), Pancreatic function and diabetes (45 papers) and Diabetes Management and Research (19 papers). Akira Ohneda collaborates with scholars based in Japan, United States and Slovakia. Akira Ohneda's co-authors include Anna M. Eisentraut, Roger H. Unger, Shoichi Yamagata, Isabel Valverde, E Aguilar-Parada, John H. Exton, Tetsuya Kuhara, Yuka Sasaki, Yoshisuke Maruhama and Shoji Ishii and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Gastroenterology.

In The Last Decade

Akira Ohneda

108 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Akira Ohneda Japan 22 1.1k 874 390 376 276 112 1.9k
Sumer Pek United States 23 949 0.9× 886 1.0× 410 1.1× 496 1.3× 395 1.4× 60 1.9k
Samuel Cataland United States 24 1.1k 1.0× 724 0.8× 341 0.9× 377 1.0× 174 0.6× 67 2.0k
Walter A. Müller United States 16 1.3k 1.2× 1.1k 1.3× 514 1.3× 505 1.3× 361 1.3× 36 2.1k
B. Willms Germany 19 1.6k 1.5× 907 1.0× 435 1.1× 756 2.0× 150 0.5× 56 2.3k
L Picon France 22 686 0.6× 720 0.8× 561 1.4× 377 1.0× 351 1.3× 69 1.8k
Jürgen Steinke United States 27 956 0.9× 761 0.9× 1.1k 2.9× 611 1.6× 511 1.9× 64 2.6k
Akira Kuroe Japan 19 819 0.8× 507 0.6× 326 0.8× 497 1.3× 157 0.6× 35 1.6k
M. A. Burnett United Kingdom 14 843 0.8× 663 0.8× 239 0.6× 509 1.4× 324 1.2× 21 1.4k
A. F. Nakhooda Canada 18 694 0.6× 748 0.9× 465 1.2× 247 0.7× 727 2.6× 27 1.7k
H S Besterman United Kingdom 18 389 0.4× 596 0.7× 218 0.6× 154 0.4× 127 0.5× 28 1.3k

Countries citing papers authored by Akira Ohneda

Since Specialization
Citations

This map shows the geographic impact of Akira Ohneda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akira Ohneda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akira Ohneda more than expected).

Fields of papers citing papers by Akira Ohneda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akira Ohneda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akira Ohneda. The network helps show where Akira Ohneda may publish in the future.

Co-authorship network of co-authors of Akira Ohneda

This figure shows the co-authorship network connecting the top 25 collaborators of Akira Ohneda. A scholar is included among the top collaborators of Akira Ohneda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akira Ohneda. Akira Ohneda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ohneda, Akira, Ryotaro Kojima, Takeya Sato, et al.. (1999). Plasma glicentin in diabetic and gastrectomized patients. Regulatory Peptides. 79(1). 55–61. 11 indexed citations
2.
Matsunaga, Naofumi, et al.. (1999). Effects of ruminal infusion of volatile fatty acids on plasma concentration of growth hormone and insulin in sheep. Domestic Animal Endocrinology. 17(1). 17–27. 29 indexed citations
3.
Kuhara, Tetsuya, et al.. (1995). Insulin and glucagon secretion in goats (Capra hircus Linnæus) exposed to cold. Comparative Biochemistry and Physiology Part C Pharmacology Toxicology and Endocrinology. 111(2). 303–309. 2 indexed citations
4.
Sasaki, I, Motoko Takahashi, Toshio Doi, et al.. (1994). Trophic effect of glicentin on intestinal mucosa during administration of elemental diet in rats. Biomedical Research-tokyo. 15. 295–298. 2 indexed citations
5.
Ohneda, Akira, Kinuko Ohneda, & Makoto Ohneda. (1993). The structure-function relationship of GLP-1-related peptides in the endocrine function of the pancreas. Digestion. 54(6). 354–355. 2 indexed citations
6.
Ohneda, Kinuko, Akira Ohneda, & Fumiaki Koizumi. (1993). Mechanism of insulin secretion by midaglizole. Diabetes Research and Clinical Practice. 19(2). 127–132. 4 indexed citations
7.
Kuhara, Tetsuya, et al.. (1993). Inhibitory Effect of Volatile Fatty Acids on GRF-Induced GH Secretion in Sheep.. Endocrine Journal. 40(5). 529–537. 21 indexed citations
8.
Kuhara, Tetsuya, et al.. (1992). Responses of Metabolic Hormones to Prolonged Intraduodenal Infusion of Amino Acids in Sheep. Nihon Chikusan Gakkaiho. 63(11). 1123–1133. 9 indexed citations
9.
Sasaki, I, Hisashi Naito, Y. Funayama, et al.. (1988). Effect of ileo-jejunal transposition on intestinal structure and function in dogs. Biomedical Research-tokyo. 9. 157–162. 5 indexed citations
10.
Ohneda, Akira, et al.. (1988). Effect of intraluminal administration of amino acids upon plasma glicentin. Diabetes Research and Clinical Practice. 5(4). 265–270. 9 indexed citations
11.
Ohneda, Akira, et al.. (1987). Glucose-induced responses of insulin and gastric inhibitory polypeptide in various animal models.. The Tohoku Journal of Experimental Medicine. 151(1). 97–104.
12.
Ohneda, Akira, et al.. (1977). Changes in glucose tolerance and insulin response in subclinical diabetes after treatment.. The Tohoku Journal of Experimental Medicine. 122(3). 199–207. 2 indexed citations
13.
Maruhama, Yoshisuke, Ryuzo Abe, FUMINOBU OKUGUCHI, & Akira Ohneda. (1977). Dietary Intake and Hyperlipidemia in Controlled Diabetic Outpatients. Diabetes. 26(2). 94–99. 10 indexed citations
14.
Ohneda, Akira, et al.. (1977). Biochemical differences between human malignant and benign insulinoma tissues.. The Tohoku Journal of Experimental Medicine. 121(3). 275–280. 4 indexed citations
15.
Ohneda, Akira, Yukihiro Kai, Shoji Ishii, et al.. (1976). Insulin and glucagon response in patients with chronic pancreatitis.. The Tohoku Journal of Experimental Medicine. 120(3). 287–298. 11 indexed citations
16.
Ohneda, Akira, et al.. (1974). Hypoglycemia Due to Apparent Autoantibodies to Insulin: Characterization of Insulin-binding Protein. Diabetes. 23(1). 41–50. 45 indexed citations
17.
Toyota, Takayoshi, Shin Sato, Akira Ohneda, & Yoshio Gotō. (1972). Diurnal Change of Plasma Insulin, Free Fatty Acids and Human Growth Hormone in Diabetics during Bonito Insulin Treatment. The Tohoku Journal of Experimental Medicine. 107(2). 167–172.
18.
Valverde, Isabel, et al.. (1968). Demonstration and Characterization of a Second Fraction of Glucagon-Like Immunoreactivity in Jejunal Extracts. The American Journal of the Medical Sciences. 255(6). 415–420. 66 indexed citations
19.
Yamagata, Shoichi, et al.. (1965). CLINICAL EFFECTS OF XYLITOL ON CARBOHYDRATE AND LIPID METABOLISM IN DIABETES. The Lancet. 286(7419). 918–921. 27 indexed citations
20.
Wakui, A, et al.. (1959). Diets and Progress of Alloxan Diabetes. The Tohoku Journal of Experimental Medicine. 69(4). 307–317. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026